FDA OKs New Hep C Rx
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
What You Need to Know About the HPV Vaccine
January is Cervical Health Awareness Month, a time to raise awareness about how women can protect themselves from HPV and cervical cancer.
No Shortage of Hepatitis C Treatments
In the last three years, there have been many advances in hepatitis C treatment. Hepatitis C is an infection that affects the liver and can lead to liver disease if left untreated.
On World AIDS Day, CDC Urges HIV Prevention Pill
Dec. 1 is World AIDS Day. And this year's theme is "The Time to Act Is Now."
Are Hep C Drugs Worth the Cost?
Newly developed drugs to treat hepatitis C infection can cost upward of $100,000 for a full course of treatment. Do the benefits of these drugs outweigh the costs?
A Potential Cure for Hep C Infection
A pill is causing quite a stir after it was suggested as a potential cure for hepatitis C.
A One-Step Test to Detect Hep C
Testing patients for hepatitis C infection might have just gotten a whole lot easier.
Combo HIV Tablet Approved
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
A New Treatment Option for HIV in Kids
In the fight against human immunodeficiency virus (HIV), one treatment may be safer than previously thought.
Teen Girls and the HPV Vaccine
In the US, routine HPV vaccination is recommended for all girls before age 13. So why are so many still not getting vaccinated?